GABA(A) receptor Pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2)

Journal of Biological Chemistry

Volumn 289, Issue 35, 2014, Pages 24102-24113

  Sizemore, Gina M ^a,b   Sizemore, Steven T ^a,c   Seachrist, Darcie D ^a   Keri, Ruth A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL MEMBRANES; DISEASES; ENZYMES; KERATIN; TUMORS;

BASAL-LIKE BREAST CANCERS; CELL SURFACE RECEPTORS; EXTRACELLULAR-REGULATED KINASE; HETEROGENEOUS DISEASE; PROGESTERONE RECEPTOR; SELECTIVE INHIBITION; TARGETED THERAPEUTICS; THERAPEUTIC POTENTIALS;

DIAGNOSIS;

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR PI; CYTOKERATIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KRT14; PROTEIN KRT17; PROTEIN KRT5; PROTEIN KRT6B; UNCLASSIFIED DRUG; GABRP PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CELL LINE; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; GABRP GENE; GENE SILENCING; HUMAN; HUMAN CELL; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL LINE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; PHYSIOLOGY; SURVIVAL;

BREAST NEOPLASMS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; MAP KINASE SIGNALING SYSTEM; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GABA-A; SURVIVAL ANALYSIS;

EID: 84906877052     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.593582     Document Type: Article

References (55)

1. Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lønning, P. E., Børresen-Dale, A. L., Brown, P. O., and Botstein, D. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752
2. Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Lønning, P., and Børresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A. 98, 10869-10874
3. Rakha, E. A., and Chan, S. (2011) Metastatic triple-negative breast cancer. Clinical Oncology 23, 587-600
4. Gaedcke, J., Traub, F., Milde, S., Wilkens, L., Stan, A., Ostertag, H., Christgen, M., von Wasielewski, R., and Kreipe, H. H. (2007) Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod. Pathol. 20, 864-870 (Pubitemid 47077270)
5. Smid, M., Wang, Y., Zhang, Y., Sieuwerts, A. M., Yu, J., Klijn, J. G., Foekens, J. A., and Martens, J. W. (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res. 68, 3108-3114
6. Luck, A. A., Evans, A. J., Green, A. R., Rakha, E. A., Paish, C., and Ellis, I. O. (2008) The influence of basal phenotype on the metastatic pattern of breast cancer. Clinical Oncology 20, 40-45
7. Symmans, W. F., Fiterman, D. J., Anderson, S. K., Ayers, M., Rouzier, R., Dunmire, V., Stec, J., Valero, V., Sneige, N., Albarracin, C., Wu, Y., Ross, J. S., Wagner, P., Theriault, R. L., Arun, B., Kuerer, H., Hess, K. R., Zhang, W., Hortobagyi, G. N., and Pusztai, L. (2005) A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr. Relat. Cancer 12, 1059-1069 (Pubitemid 41815797)
8. Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M. L., Gyorki, D. E., Ward, T., Partanen, A., Feleppa, F., Huschtscha, L. I., Thorne, H. J., Fox, S. B., Yan, M., French, J. D., Brown, M. A., Smyth, G. K., Visvader, J. E., and Lindeman, G. J. (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15, 907-913
9. Johnson, S. K., and Haun, R. S. (2005) The γ-aminobutyric acid A receptor pi subunit is overexpressed in pancreatic adenocarcinomas. JOP: Journal of the Pancreas 6, 136-142 (Pubitemid 41573817)
10. Takehara, A., Hosokawa, M., Eguchi, H., Ohigashi, H., Ishikawa, O., Nakamura, Y., and Nakagawa, H. (2007) γ-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res. 67, 9704-9712 (Pubitemid 47621217)
11. Hedblom, E., and Kirkness, E. F. (1997) A novel class of GABAA receptor subunit in tissues of the reproductive system. J. Biol. Chem. 272, 15346-15350 (Pubitemid 27255557)
12. Zafrakas, M., Chorovicer, M., Klaman, I., Kristiansen, G., Wild, P. J., Heindrichs, U., Knüchel, R., and Dahl, E. (2006) Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue. Int. J. Cancer 118, 1453-1459
13. Quezada, M., Henríquez, S., Vargas, M., Cardenas, H., Tapia, A., Rios, M., Salvatierra, A. M., Orihuela, P. A., Croxatto, H. B., and Velasquez, L. (2006) Proenkephalin A and the gamma-aminobutyric acid A receptor pi subunit: expression, localization, and dynamic changes in human secretory endometrium. Fertility Sterility 86, 1750-1757
14. Sadeghi, H., and Taylor, H. S. (2010) HOXA10 regulates endometrial GABAA {pi} receptor expression and membrane translocation. Am. J. Physiol. 298, E889-E893
15. Mazurkiewicz, M., Opolski, A., Wietrzyk, J., Radzikowski, C., and Kleinrok, Z. (1999) GABA level and GAD activity in human and mouse normal and neoplastic mammary gland. J. Exp. Clin. Cancer Res. 18, 247-253 (Pubitemid 29359412)
16. Neman, J., Termini, J., Wilczynski, S., Vaidehi, N., Choy, C., Kowolik, C. M., Li, H., Hambrecht, A. C., Roberts, E., and Jandial, R. (2014) Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc. Natl. Acad. Sci. U.S.A. 111, 984-989
17. Garib, V., Niggemann, B., Zänker, K. S., Brandt, L., and Kubens, B. S. (2002) Influence of non-volatile anesthetics on the migration behavior of the human breast cancer cell line MDA-MB-468. Acta anaesthesiologica Scandinavica 46, 836-844 (Pubitemid 34800077)
18. Garib, V., Lang, K., Niggemann, B., Zänker, K. S., Brandt, L., and Dittmar, T. (2005) Propofol-induced calcium signalling and actin reorganization within breast carcinoma cells. Eur. J. Anaesthesiol. 22, 609-615 (Pubitemid 41097864)
19. Azuma, H., Inamoto, T., Sakamoto, T., Kiyama, S., Ubai, T., Shinohara, Y., Maemura, K., Tsuji, M., Segawa, N., Masuda, H., Takahara, K., Katsuoka, Y., and Watanabe, M. (2003) γ-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res. 63, 8090-8096 (Pubitemid 37549451)
20. Abdul, M., McCray, S. D., and Hoosein, N. M. (2008) Expression of γ-aminobutyric acid receptor (subtype A) in prostate cancer. Acta Oncologica 47, 1546-1550
21. Inamoto, T., Azuma, H., Sakamoto, T., Kiyama, S., Ubai, T., Kotake, Y., Watanabe, M., and Katsuoka, Y. (2007) Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by γ-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinases. Cancer Investig. 25, 574-583 (Pubitemid 350135744)
22. Liu, Y., Li, Y. H., Guo, F. J., Wang, J. J., Sun, R. L., Hu, J. Y., and Li, G. C. (2008) γ-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed γ-aminobutyric acid A receptor α 3 subunit. World J. Gastroenterol. 14, 7175-7182
23. Joseph, J., Niggemann, B., Zaenker, K. S., and Entschladen, F. (2002) The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res. 62, 6467-6469 (Pubitemid 35364108)
24. Miao, Y., Zhang, Y., Wan, H., Chen, L., and Wang, F. (2010) GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomedicine Pharmacotherapy 64, 583-588
25. Curtis, C., Shah, S. P., Chin, S. F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y., Gräf, S., Ha, G., Haffari, G., Bashashati, A., Russell, R., McKinney, S., METABRIC Group, Langerød, A., Green, A., Provenzano, E., Wishart, G., Pinder, S., Watson, P., Markowetz, F., Murphy, L., Ellis, I., Purushotham, A., Børresen-Dale, A. L., Brenton, J. D., Tavaré, S., Caldas, C., and Aparicio, S. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352
26. Esserman, L. J., Berry, D. A., Cheang, M. C., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., Lenburg, M. E., Buxton, M. B., Davis, S. E., van't Veer, L. J., Hudis, C., Chin, K., Wolf, D., Krontiras, H., Montgomery, L., Tripathy, D., Lehman, C., Liu, M. C., Olopade, O. I., Rugo, H. S., Carpenter, J. T., Livasy, C., Dressler, L., Chhieng, D., Singh, B., Mies, C., Rabban, J., Chen, Y. Y., Giri, D., Au, A., Hylton, N., and I-SPY1 Trial Investigators (2012) Chemotherapy response and recur-rence- free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res. Treat 132, 1049-1062
27. Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., and Massagué, J. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009
28. Dontu, G., Jackson, K. W., McNicholas, E., Kawamura, M. J., Abdallah, W. M., and Wicha, M. S. (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 6, R605-R615
29. Bernardo, G. M., Bebek, G., Ginther, C. L., Sizemore, S. T., Lozada, K. L., Miedler, J. D., Anderson, L. A., Godwin, A. K., Abdul-Karim, F. W., Slamon, D. J., and Keri, R. A. (2013) FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene 32, 554-563
30. Abramoff, M. D., Magelhaes, P. J., and Ram, S. J. (2004) Image Processing with ImageJ. Biophotonics Int. 11, 36-42
31. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527 (Pubitemid 44854747)
32. Charafe-Jauffret, E., Ginestier, C., Monville, F., Finetti, P., Adélaïde, J., Cervera, N., Fekairi, S., Xerri, L., Jacquemier, J., Birnbaum, D., and Bertucci, F. (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25, 2273-2284
33. Taylor, A. P., Leon, E., and Goldenberg, D. M. (2010) Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br. J. Cancer 103, 82-89
34. Busch, T., Armacki, M., Eiseler, T., Joodi, G., Temme, C., Jansen, J., von Wichert, G., Omary, M. B., Spatz, J., and Seufferlein, T. (2012) Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. J. Cell Sci. 125, 2148-2159
35. Rakha, E. A., Reis-Filho, J. S., and Ellis, I. O. (2008) Basal-like breast cancer: a critical review. J. Clin. Oncol. 26, 2568-2581
36. Creighton, C. J., Hilger, A. M., Murthy, S., Rae, J. M., Chinnaiyan, A. M., and El-Ashry, D. (2006) Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors. Cancer Res. 66, 3903-3911
37. Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007) GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215-1284 (Pubitemid 350041471)
38. Yang, S., Zhang, J. J., and Huang, X. Y. (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15, 124-134
39. Huang, C., Jacobson, K., and Schaller, M. D. (2004) MAP kinases and cell migration. J. Cell Science 117, 4619-4628 (Pubitemid 39433429)
40. Meng, X. N., Jin, Y., Yu, Y., Bai, J., Liu, G. Y., Zhu, J., Zhao, Y. Z., Wang, Z., Chen, F., Lee, K. Y., and Fu, S. B. (2009) Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br. J. Cancer 101, 327-334
41. Zhang, W., Dang, E., Shi, X., Jin, L., Feng, Z., Hu, L., Wu, Y., and Wang, G. (2012) The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One 7, e40797
42. Hoeflich, K. P., O'Brien, C., Boyd, Z., Cavet, G., Guerrero, S., Jung, K., Januario, T., Savage, H., Punnoose, E., Truong, T., Zhou, W., Berry, L., Murray, L., Amler, L., Belvin, M., Friedman, L. S., and Lackner, M. R. (2009) In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin. Cancer Res. 15, 4649-4664
43. Mirzoeva, O. K., Das, D., Heiser, L. M., Bhattacharya, S., Siwak, D., Gendelman, R., Bayani, N., Wang, N. J., Neve, R. M., Guan, Y., Hu, Z., Knight, Z., Feiler, H. S., Gascard, P., Parvin, B., Spellman, P. T., Shokat, K. M., Wyrobek, A. J., Bissell, M. J., McCormick, F., Kuo, W. L., Mills, G. B., Gray, J. W., and Korn, W. M. (2009) Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. Cancer Res. 69, 565-572
44. Haeseler, G., Karst, M., Foadi, N., Gudehus, S., Roeder, A., Hecker, H., Dengler, R., and Leuwer, M. (2008) High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br. J. Pharmacol. 155, 265-275
45. Fowler, C. J. (2004) Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. Trends Pharmacol. Sci. 25, 59-61
46. Young, S. Z., and Bordey, A. (2009) GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology 24, 171-185
47. Hendrix, M. J., Seftor, E. A., Chu, Y. W., Trevor, K. T., and Seftor, R. E. (1996) Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525 (Pubitemid 27067169)
48. Ballestrem, C., Wehrle-Haller, B., Hinz, B., and Imhof, B. A. (2000) Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration. Mol. Biol. Cell 11, 2999-3012 (Pubitemid 32107080)
49. Cheung, K. J., Gabrielson, E., Werb, Z., and Ewald, A. J. (2013) Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639-1651
50. Omary, M. B., Ku, N. O., Tao, G. Z., Toivola, D. M., and Liao, J. (2006) "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31, 383-394 (Pubitemid 44038919)
51. Backus, J., Laughlin, T., Wang, Y., Belly, R., White, R., Baden, J., Justus Min, C., Mannie, A., Tafra, L., Atkins, D., and Verbanac, K. M. (2005) Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J. Mol. Diagn. 7, 327-336 (Pubitemid 41149647)
52. Reinholz, M. M., Nibbe, A., Jonart, L. M., Kitzmann, K., Suman, V. J., Ingle, J. N., Houghton, R., Zehentner, B., Roche, P. C., and Lingle, W. L. (2005) Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin. Cancer Res. 11, 3722-3732 (Pubitemid 40685589)
53. Lacroix, M. (2006) Significance, detection and markers of disseminated breast cancer cells. Endocr. Relat. Cancer 13, 1033-1067
54. Zehentner, B. K., Secrist, H., Hayes, D. C., Zhang, X., Ostenson, R. C., Loop, S., Goodman, G., Houghton, R. L., and Persing, D. H. (2006) Detection of circulating tumor cells in peripheral blood of breast cancer patients during or after therapy using a multigene real-time RT-PCR assay. Molecular Diagnosis Therapy 10, 41-47
55. Zehentner, B. K., Dillon, D. C., Jiang, Y., Xu, J., Bennington, A., Molesh, D. A., Zhang, X., Reed, S. G., Persing, D., and Houghton, R. L. (2002) Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin. Chem. 48, 1225-1231 (Pubitemid 34809830)